Karyopharm Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Karyopharm Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Karyopharm Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 125M shares, a 9.41% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 125M +10.8M +9.41% Oct 31, 2024 10-Q 2024-11-05
Q2 2024 125M +10.3M +9.03% Jul 31, 2024 10-Q 2024-08-06
Q1 2024 118M +3.7M +3.25% May 3, 2024 10-Q 2024-05-08
Q3 2023 115M +33.4M +41.1% Oct 27, 2023 10-Q 2023-11-02
Q2 2023 114M +34.5M +43.3% Jul 28, 2023 10-Q 2023-08-02
Q1 2023 114M +34.6M +43.6% Apr 28, 2023 10-Q 2023-05-04
Q4 2022 113M Feb 10, 2023 10-K 2023-02-17
Q3 2022 81.2M +5.61M +7.42% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 79.8M +4.31M +5.71% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 79.4M +4.33M +5.76% Apr 29, 2022 10-Q 2022-05-05
Q3 2021 75.5M +1.95M +2.65% Oct 27, 2021 10-Q 2021-11-03
Q2 2021 75.5M +2.02M +2.75% Jul 28, 2021 10-Q 2021-08-05
Q1 2021 75.1M +1.97M +2.7% Apr 29, 2021 10-Q 2021-05-04
Q3 2020 73.6M +10.8M +17.2% Oct 28, 2020 10-Q 2020-11-02
Q2 2020 73.5M +11.6M +18.7% Jul 30, 2020 10-Q 2020-08-04
Q1 2020 73.1M +12.3M +20.1% Apr 30, 2020 10-Q 2020-05-05
Q4 2019 65.5M Feb 14, 2020 10-K 2020-02-26
Q3 2019 62.8M +2.08M +3.43% Oct 29, 2019 10-Q 2019-11-04
Q2 2019 61.9M +1.36M +2.24% Jul 31, 2019 10-Q 2019-08-07
Q1 2019 60.9M +11.2M +22.6% Apr 30, 2019 10-Q 2019-05-09
Q3 2018 60.7M +13.5M +28.7% Nov 2, 2018 10-Q 2018-11-08
Q2 2018 60.6M +13.4M +28.5% Aug 2, 2018 10-Q 2018-08-07
Q1 2018 49.7M +7.75M +18.5% Mar 9, 2018 10-K 2018-03-15
Q3 2017 47.2M +5.94M +14.4% Oct 30, 2017 10-Q 2017-11-02
Q2 2017 47.1M +11.1M +31% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 41.9M +6.02M +16.8% Mar 10, 2017 10-K 2017-03-16
Q3 2016 41.2M +5.51M +15.4% Nov 2, 2016 10-Q 2016-11-07
Q2 2016 36M +278K +0.78% Jul 31, 2016 10-Q 2016-08-04
Q1 2016 35.9M +198K +0.56% Mar 7, 2016 10-K 2016-03-15
Q3 2015 35.7M +3.03M +9.27% Nov 4, 2015 10-Q 2015-11-09
Q2 2015 35.7M +3.04M +9.31% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 35.7M +5.93M +19.9% Mar 11, 2015 10-K 2015-03-13
Q3 2014 32.7M Nov 4, 2014 10-Q 2014-11-10
Q2 2014 32.7M Jul 31, 2014 10-Q 2014-08-07
Q1 2014 29.8M Mar 14, 2014 10-K 2014-03-21
Q4 2013 29.7M Dec 16, 2013 10-Q/A 2013-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.